Loading...

Quinlan Sievers, MD, PhD

Title(s)Resident Physician, Medicine
SchoolSchool of Medicine
Phone--
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Harvard Medical School, Boston, MAMD/PhD2019Cancer Biology
    Lab of Cathy Wu, MD, DFCI, Boston, MALab technician2011Tumor immunology, therapeutic vaccination
    Williams College, Williamstown, MABA2009Biology/Studio Art

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K. Nature. 2020 Jun 03. Slabicki M, Kozicka Z, Petzold G, Li YD, Manojkumar M, Bunker RD, Donovan KA, Sievers QL, Koeppel J, Suchyta D, Sperling AS, Fink EC, Gasser JA, Wang LR, Corsello SM, Sellar RS, Jan M, Gillingham D, Scholl C, Fröhling S, Golub TR, Fischer ES, Thomä NH, Ebert BL. PMID: 32494016.
      View in: PubMed   Mentions: 2     Fields:    
    2. Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogs. Blood. 2019 07 11; 134(2):160-170. Sperling AS, Burgess M, Keshishian H, Gasser JA, Bhatt S, Jan M, Slabicki M, Sellar RS, Fink EC, Miller PG, Liddicoat BJ, Sievers QL, Sharma R, Adams DN, Olesinski EA, Fulciniti M, Udeshi ND, Kuhn E, Letai A, Munshi NC, Carr SA, Ebert BL. PMID: 31043423.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. Science. 2018 11 02; 362(6414). Sievers QL, Petzold G, Bunker RD, Renneville A, Slabicki M, Liddicoat BJ, Abdulrahman W, Mikkelsen T, Ebert BL, Thomä NH. PMID: 30385546.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    4. Genome-wide screen identifies cullin-RING ligase machinery required for lenalidomide-dependent CRL4CRBN activity. Blood. 2018 09 20; 132(12):1293-1303. Sievers QL, Gasser JA, Cowley GS, Fischer ES, Ebert BL. PMID: 30042095.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    Quinlan's Networks
    Concepts (19)
    Derived automatically from this person's publications.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _